<DOC>
	<DOCNO>NCT01266395</DOCNO>
	<brief_summary>Observational study know Impact morning symptom clinical control COPD patient . 1200 patient include General practitioner ( GPs ) pneumologists . Objective : establish difference impact COPD daily activity morning symptom measure questionnaire daily life activity ( Capacity Daily Living Morning ( CDLM ) , Global Chest Symptoms Questionnaire ( GCSQ ) )</brief_summary>
	<brief_title>Impact Morning Symptoms Clinical Control Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patient sign informed consent form Patients sex , &gt; 40 year . Patients diagnose COPD accord global consensus definition , classification management disease ( GOLD ) criterion : postbronchodilator force expiratory volume 1 ( FEV1 ) / force vital capacity ( FVC ) &lt; 70 % postbronchodilator FEV1 &lt; 80 % ( stage II , III IV ) Participating epidemiological study clinical trial Patient respiratory disease COPD ( eg bronchial asthma , cystic fibrosis , severe bronchiectasis , restrictive lung disease , cancer , etc. ) . Patients mild COPD : FEV1 &gt; 80 %</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>morning symptom COPD</keyword>
</DOC>